К. К. Лактионов - Researcher Profile

Publications

2 shown

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok , Yi‐Long Wu , Iveta Kudaba +97 more

2019 The Lancet 3175 citations

Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer

Yi‐Long Wu , Masahiro Tsuboi , Jie He +21 more

In patients with stage IB to IIIA <i>EGFR</i> mutation-positive NSCLC, disease-free survival was significantly longer among those who received osimertinib than among those who r...

2020 New England Journal of Medicine 1609 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,784
Institution: Russian Cancer Research Center NN Blokhin

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-4469-502X

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.